Leaflet ZIBOR 3500UI / 0.2ml solution for injection
Indicated for: prevention and treatment of thromboembolism
Route of administration: injectable
Substance: bemiparin (anticoagulant)
ATC: B01AB12 (Blood and blood forming organs | Antithrombotic agents | Heparin group)
Dose adjustment may be needed in kidney disease.
This medicine may have important interactions with other medicines.
This medicine is subject to additional monitoring.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
This medicine may increase the risk of bleeding.
Bemiparin is an anticoagulant medication used for the prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism. It is a low molecular weight heparin that inhibits coagulation factors Xa and IIa, preventing blood clot formation.
The medication is administered via subcutaneous injection, usually once daily, as directed by a doctor. The dosage is adjusted based on the patient's weight and the purpose of treatment (prophylaxis or therapy).
Common side effects include bleeding, bruising at the injection site, and elevated liver enzyme levels. In rare cases, more severe adverse effects such as heparin-induced thrombocytopenia or severe bleeding may occur.
Bemiparin is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions.
General data about ZIBOR 3500UI / 0.2ml
- Substance: bemiparin
- Date of latest medicines list: 01-04-2025
- Product code: W70978001
- Concentration: 3500UI / 0.2ml
- Pharmaceutical form: solution for injection
- Quantity: 2
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for bemiparin
Concentrations available for bemiparin
- 25000UI anti-XA/ml
- 2500UI/0.2ml
- 3500UI/0.2ml
- 5000UI/0.2ml